Literature DB >> 11420319

Factors affecting the incidence of chronic lung disease of prematurity in 1987, 1992, and 1997.

B N Manktelow1, E S Draper, S Annamalai, D Field.   

Abstract

OBJECTIVE: To determine changes in the incidence of chronic lung disease of prematurity between 1987, 1992, and 1997.
METHODS: Observational study based on data derived from a geographically defined population: Trent Health Region, United Kingdom. Three time periods were compared: 1 February 1987 to 31 January 1988 (referred to as 1987); 1 April 1992 to 31 March 1993 (referred to as 1992); 1997. All infants of < or = 32 completed weeks gestation born to Trent resident mothers within the study periods and admitted to a neonatal unit were included. Rates of chronic lung disease were determined using two definitions: (a) infants who remained dependent on active respiratory support or increased oxygen at 28 days of age; (b) infants who remained dependent on active respiratory support or increased oxygen at a corrected age of 36 weeks gestation.
RESULTS: Between 1987 and 1992 there was a fall in the birth rate, but a significant increase was noted in the number of babies of < or = 32 weeks gestation admitted to a neonatal unit. There was no significant change in survival when the two groups of infants were directly compared. However, mean gestation and birth weight fell. Adjusting for this change showed a significant improvement in survival (28 day survival: odds ratio (OR) = 1.69; 95% confidence interval (95% CI) = 1.23 to 2.33. Survival to 36 week corrected gestation: OR = 1.45; 95% CI = 1.06 to 1.98). These changes were accompanied by a large increase in the incidence of chronic lung disease even after allowing for the change in population characteristics (28 day definition: OR = 2.20; 95% CI = 1.47 to 3.30. 36 week definition: OR = 3.04; 95% CI = 1.91 to 4.83). Between 1992 and 1997 a different pattern emerged. There was a further increase in the number of babies admitted for neonatal care at </= 32 weeks gestation despite a continuing fall in overall birth rate. Survival, using both raw data and data corrected for changes in gestation and birth weight, improved significantly in 1997 (adjusted data: 28 day survival: OR = 1.72 (95% CI = 1.22 to 2.38); survival to 36 week corrected gestation: OR = 1.90 (95% CI = 1.36 to 2.64)). Rates of chronic lung disease showed no significant change between 1992 and 1997 despite improved survival (adjusted data: 28 day definition: OR = 0.72 (95% CI = 0.50 to 1.03); 36 week definition: OR = 0.88 (95% CI = 0.61 to 1.26).
CONCLUSIONS: Current high rates of chronic lung disease are the result of policies to offer neonatal intensive care more widely to the most immature infants. Recent improvements in survival have been achieved without further increases in the risk of infants developing chronic lung disease.

Entities:  

Mesh:

Year:  2001        PMID: 11420319      PMCID: PMC1721286          DOI: 10.1136/fn.85.1.f33

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  15 in total

1.  Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period.

Authors:  A T Shennan; M S Dunn; A Ohlsson; K Lennox; E M Hoskins
Journal:  Pediatrics       Date:  1988-10       Impact factor: 7.124

2.  Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants.

Authors:  G H Cassell; K B Waites; D T Crouse; P T Rudd; K C Canupp; S Stagno; G R Cutter
Journal:  Lancet       Date:  1988-07-30       Impact factor: 79.321

Review 3.  Scientific basis and therapeutic regimens for use of antenatal glucocorticoids.

Authors:  P L Ballard; R A Ballard
Journal:  Am J Obstet Gynecol       Date:  1995-07       Impact factor: 8.661

4.  Early treatment with nasal continuous positive airway pressure in very low-birth-weight infants.

Authors:  J Kamper; K Wulff; C Larsen; S Lindequist
Journal:  Acta Paediatr       Date:  1993-02       Impact factor: 2.299

5.  "Minitouch" treatment of very low-birth-weight infants.

Authors:  T Jacobsen; J Grønvall; S Petersen; G E Andersen
Journal:  Acta Paediatr       Date:  1993-11       Impact factor: 2.299

Review 6.  Outcomes of children of extremely low birthweight and gestational age in the 1990's.

Authors:  M Hack; A A Fanaroff
Journal:  Early Hum Dev       Date:  1999-01       Impact factor: 2.079

7.  Chronic oxygen dependency in infants born at 24-32 weeks' gestation: the role of antenatal and neonatal factors.

Authors:  D A Todd; A Jana; E John
Journal:  J Paediatr Child Health       Date:  1997-10       Impact factor: 1.954

8.  Improved outcomes following the introduction of surfactant to an Australian neonatal unit.

Authors:  P Beeby; D Chan; D Henderson-Smart
Journal:  J Paediatr Child Health       Date:  1996-06       Impact factor: 1.954

9.  Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia.

Authors:  B H Yoon; R Romero; J K Jun; K H Park; J D Park; F Ghezzi; B I Kim
Journal:  Am J Obstet Gynecol       Date:  1997-10       Impact factor: 8.661

10.  Very-low-birth-weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, May 1991 through December 1992.

Authors:  A A Fanaroff; L L Wright; D K Stevenson; S Shankaran; E F Donovan; R A Ehrenkranz; N Younes; S B Korones; B J Stoll; J E Tyson
Journal:  Am J Obstet Gynecol       Date:  1995-11       Impact factor: 8.661

View more
  14 in total

1.  Outcomes for high risk New Zealand newborn infants in 1998-1999: a population based, national study.

Authors:  A E Cust; B A Darlow; D A Donoghue
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

2.  Improved outcomes for very low birthweight infants: evidence from New Zealand national population based data.

Authors:  B A Darlow; A E Cust; D A Donoghue
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

3.  Does sustained lung inflation at resuscitation reduce lung injury in the preterm infant?

Authors:  A E Harling; M W Beresford; G S Vince; M Bates; C W Yoxall
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-04-29       Impact factor: 5.747

4.  RSV infection in prematurely born infants.

Authors:  S Deshpande
Journal:  Thorax       Date:  2006-06       Impact factor: 9.139

5.  Population-based study of bronchopulmonary dysplasia in very low birth weight infants in Switzerland.

Authors:  Juliane Hentschel; Thomas M Berger; Alois Tschopp; Martina Müller; Mark Adams; Hans-Ulrich Bucher
Journal:  Eur J Pediatr       Date:  2005-02-15       Impact factor: 3.183

6.  Survival of extremely premature babies in a geographically defined population: prospective cohort study of 1994-9 compared with 2000-5.

Authors:  David J Field; Jon S Dorling; Bradley N Manktelow; Elizabeth S Draper
Journal:  BMJ       Date:  2008-05-09

7.  Bronchopulmonary dysplasia - trends over three decades.

Authors:  Zofia Zysman-Colman; Genevieve M Tremblay; Suhair Bandeali; Jennifer S Landry
Journal:  Paediatr Child Health       Date:  2013-02       Impact factor: 2.253

8.  Gender differences in respiratory symptoms in 19-year-old adults born preterm.

Authors:  Elianne J L E Vrijlandt; Jorrit Gerritsen; H Marike Boezen; Eric J Duiverman
Journal:  Respir Res       Date:  2005-10-13

9.  Outcome following patent ductus arteriosus ligation in premature infants: a retrospective cohort analysis.

Authors:  Lleona C L Lee; Angela Tillett; Robert Tulloh; Robert Yates; Wilf Kelsall
Journal:  BMC Pediatr       Date:  2006-05-11       Impact factor: 2.125

10.  Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study.

Authors:  Joanna Murray; Alex Bottle; Mike Sharland; Neena Modi; Paul Aylin; Azeem Majeed; Sonia Saxena
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.